Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized contro...
Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized controlled trial
About this item
Full title
Author / Creator
Østergaard, Lauge , Pries-Heje, Mia Marie , Hasselbalch, Rasmus Bo , Rasmussen, Magnus , Åkesson, Per , Horvath, Robert , Povlsen, Jonas , Gill, Sabine , Bruun, Niels Eske , Müllertz, Katrine , Tuxen, Christian Ditlev , Ihlemann, Nikolaj , Helweg-Larsen, Jannik , Moser, Claus , Fosbøl, Emil Loldrup , Bundgaard, Henning and Iversen, Kasper
Publisher
Philadelphia: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
The optimal antibiotic treatment length for infective endocarditis (IE) is uncertain. International guidelines recommend treatment duration of up to 6 weeks for patients with left-sided IE but are primarily based on historical data and expert opinion. Efficacies of modern therapies, fast recovery seen in many patients with IE, and complications to...
Alternative Titles
Full title
Accelerated treatment of endocarditis—The POET II trial: Rationale and design of a randomized controlled trial
Authors, Artists and Contributors
Author / Creator
Pries-Heje, Mia Marie
Hasselbalch, Rasmus Bo
Rasmussen, Magnus
Åkesson, Per
Horvath, Robert
Povlsen, Jonas
Gill, Sabine
Bruun, Niels Eske
Müllertz, Katrine
Tuxen, Christian Ditlev
Ihlemann, Nikolaj
Helweg-Larsen, Jannik
Moser, Claus
Fosbøl, Emil Loldrup
Bundgaard, Henning
Iversen, Kasper
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2425001784
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2425001784
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2020.05.012
